Monday, 23 September 2019 11:30 GMT
img

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation




(MENAFN - ABN Newswire)

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, presented at the Monsoon Communications Twilight Investor Briefing, yesterday evening, in Melbourne.
To view the presentation, please visit:
https://abnnewswire.net/lnk/2646IK40

Anatara Lifesciences ASX ANRAnatara Lifesciences( ASX:ANR ) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visitwww.anataralifesciences.com .

     

Investor and Media inquiriesSteven LydeamoreChief Executive OfficerAnatara Lifesciences LtdT: +61-438-027-172E: ue MacLemanChairAnatara Lifesciences LtdT: +61-437-211-200E:

MENAFN2208201901110000ID1098915119


Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

  Most popular stories  

Day | Week | Month